Back
  1. Home
  2. Profile of Alizée LEBEAU (ULiège)
Profil

LEBEAU Alizée

Département de médecine interne > Service d'oncologie médicale

See author's contact details
ORCID
0000-0002-1144-3232
Main Referenced Co-authors
Herfs, Michael  (19)
Bruyère, Diane  (18)
Delvenne, Philippe  (18)
Hubert, Pascale  (18)
Roncarati, Patrick  (18)
Main Referenced Keywords
Cancer (3); HPV (3); Pharmacology (3); Cell Biology (2); Cellular and Molecular Neuroscience (2);
Main Referenced Unit & Research Centers
Giga-Cancer - ULiège [BE] (3)
Main Referenced Disciplines
Oncology (24)
Biochemistry, biophysics & molecular biology (7)
Anatomy (cytology, histology, embryology...) & physiology (3)
Hematology (1)
Laboratory medicine & medical technology (1)

Publications (total 38)

The most downloaded
91 downloads
Gucciardo, F., Pirson, S., Baudin, L., Lebeau, A., & Noël, A. (22 April 2022). uPARAP/Endo180: a multifaceted protein of mesenchymal cells. Cellular and Molecular Life Sciences, 79 (5), 255. doi:10.1007/s00018-022-04249-7 https://hdl.handle.net/2268/290556

The most cited

101 citations (OpenAlex)

Hubert, P., RONCARATI, P., Demoulin, S., Pilard, C., Ancion, M., Reynders, C., Lerho, T., Bruyère, D., Lebeau, A., Radermecker, C., Meunier, M., Nokin, M.-J., Hendrick, E., Peulen, O., Delvenne, P., & Herfs, M. (2021). Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy. Journal for ImmunoTherapy of Cancer, 9 ((3)), 001966. doi:10.1136/jitc-2020-001966 https://hdl.handle.net/2268/258085

Salmon, A.* , LEBEAU, A.* , Streel, S., Dheur, A., Schoenen, S., Goffin, F., Gonne, E., Kridelka, F., Kakkos, A.* , & Gennigens, C.*. (22 June 2024). Locally advanced and metastatic endometrial cancer: Current and emerging therapies. Cancer Treatment Reviews, 129, 102790. doi:10.1016/j.ctrv.2024.102790
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Bruyere, D., RONCARATI, P., Lebeau, A., Lerho, T., Poulain, F., Hendrick, E., Pilard, C., Reynders, C., Ancion, M., Luyckx, M., Renard, M., Jacob, Y., Twizere, J.-C., Peiffer, R., Peulen, O., Delvenne, P., Hubert, P., McBride, A., Gillet, N., ... Herfs, M. (2023). Human papillomavirus E6/E7 oncoproteins promote radiotherapy-mediated tumor suppression by globally hijacking host DNA damage repair. Theranostics, 13 (3), 1130 - 1149. doi:10.7150/thno.78091
Peer Reviewed verified by ORBi

Schmitz, L., Pirotte, M., Lebeau, A., Ernst, M., Fillet, M., DEVEY, A., SCHMITT, J., Cobraiville, G., BINSFELD, M., Gofflot, S., Beguin, Y.* , & Vertenoeil, G.*. (2023). Alterations of erythropoiesis in Covid-19 patients: prevalence of positive Coombs tests and iron metabolism. Therapeutic Advances in Hematology, 14, 20406207231199837. doi:10.1177/20406207231199837
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Pirson, S., Gautier, M., Deroye, J., Blacher, S., Lebeau, A., Gucciardo, F., Baudin, L., Rouaud, L., Gilles, C., & Noël, A. (10 November 2022). Identification of a new partner of uPARAP/Endo180 involved in lymphangiogenesis processes [Poster presentation]. Imagine all the Vessels.

Gucciardo, F., Lebeau, A., Pirson, S., Blacher, S., Gautier, M., & Noël, A. (01 November 2022). Mechanistical investigation of the lymphatic morphogenesis during lymphedema [Poster presentation]. Gordon Research Conference, Barga, Italy.

Buntinx, F.* , Lebeau, A.* , Gillot, L., Baudin, L., Ndong Penda, R., Morfoisse, F., LALLEMAND, F., Vottero, G., NIZET, C., Nizet, J.-L., Blacher, S., & Noël, A. (18 October 2022). Single and combined impacts of irradiation and surgery on lymphatic vasculature and fibrosis associated to secondary lymphedema. Frontiers in Pharmacology, 13. doi:10.3389/fphar.2022.1016138
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Pirson, S., Gautier, M., Deroye, J., Lebeau, A., Gucciardo, F., Baudin, L., Rouaud, L., Gilles, C., & Noël, A. (30 September 2022). Identification of a new partner of uPARAP/Endo180 involved in lymphangiogenesis processes [Poster presentation]. BACR, Gand, Belgium.

Pirson, S., Gautier, M., Deroye, J., Lebeau, A., Gucciardo, F., Baudin, L., Rouaud, L., & Noël, A. (06 September 2022). Identification of a new partner of uPARAP/Endo180 involved in lymphangiogenesis processes [Poster presentation]. Giga Day, Liège, Belgium.

Gillot, L., Lebeau, A., Baudin, L., POTTIER, C., Louis, T., Durré, T., Longuespée, R., Mazzucchelli, G., NIZET, C., BLACHER, S., KRIDELKA, F., & Noël, A. (14 May 2022). Periostin in lymph node pre-metastatic niches governs lymphatic endothelial cell functions and metastatic colonization. Cellular and Molecular Life Sciences, 79 (6), 295. doi:10.1007/s00018-022-04262-w
Peer Reviewed verified by ORBi

Gucciardo, F., Pirson, S., Baudin, L., Lebeau, A., & Noël, A. (22 April 2022). uPARAP/Endo180: a multifaceted protein of mesenchymal cells. Cellular and Molecular Life Sciences, 79 (5), 255. doi:10.1007/s00018-022-04249-7
Peer Reviewed verified by ORBi

Gucciardo, F., Pirson, S., Lebeau, A., BLACHER, S., & Noël, A. (08 April 2022). Mechanistic investigation of the lymphatic morphogenesis during cancer progression [Poster presentation]. Télévie Seminar, Liège, Belgium.

Lebeau, A.* , Bruyère, D.* , RONCARATI, P., Peixoto, P., Hervouet, E., COBRAIVILLE, G., Taminiau, B., Masson, M., Gallego, C., Mazzucchelli, G., Smargiasso, N., Fleron, M., Baiwir, D., Hendrick, E., Pilard, C., Lerho, T., Reynders, C., Ancion, M., GREIMERS, R., ... Herfs, M. (28 February 2022). HPV infection alters vaginal microbiome through down-regulating host mucosal innate peptides used by Lactobacilli as amino acid sources. Nature Communications, 13 (1), 1076. doi:10.1038/s41467-022-28724-8
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Pirson, S., Gautier, M., Lebeau, A., Gucciardo, F., & Noël, A. (14 December 2021). Identification of a new partner of uPARAP/Endo180 involved in migration of lymphatic endothelial cells [Poster presentation]. Giga-Cancer Day.

Gucciardo, F., Pirson, S., Lebeau, A., BLACHER, S., & Noël, A. (17 November 2021). Mechanistic investigation of the lymphatic morphogenesis during cancer progression [Poster presentation]. 9ème congrès de la Société Francaise d'Angiogenèse, Nantes, France.

Wuidar, V., Gillot, L., Dias Da Silva, I., Lebeau, A., Gallez, A., & Pequeux, C. (2021). Sex-based differences in the tumor microenvironment. In Tumor Microenvironment - Novel Concepts. Springer Nature. doi:10.1007/978-3-030-73119-9_23
Peer reviewed

Hubert, P., RONCARATI, P., Demoulin, S., Pilard, C., Ancion, M., Reynders, C., Lerho, T., Bruyère, D., Lebeau, A., Radermecker, C., Meunier, M., Nokin, M.-J., Hendrick, E., Peulen, O., Delvenne, P., & Herfs, M. (2021). Extracellular HMGB1 blockade inhibits tumor growth through profoundly remodeling immune microenvironment and enhances checkpoint inhibitor-based immunotherapy. Journal for ImmunoTherapy of Cancer, 9 ((3)), 001966. doi:10.1136/jitc-2020-001966
Peer Reviewed verified by ORBi

Pilard, C., RONCARATI, P., Hendrick, E., Lebeau, A., Bruyère, D., Lerho, T., Ancion, M., Reynders, C., DELVENNE, P., Herfs, M., & Hubert, P. (01 October 2020). P08.03 Combining PD-1/PD-L1 blockade and RANKL inhibitors to treat breast cancers unresponsive to standard therapy. Journal for ImmunoTherapy of Cancer, 8 (Suppl 2), 50-A51. doi:10.1136/jitc-2020-ITOC7.99

Pilard, C., RONCARATI, P., Hendrick, E., Lebeau, A., Bruyère, D., Lerho, T., Ancion, M., Reynders, C., DELVENNE, P., Herfs, M., & Hubert, P. (07 February 2020). Combining PD-1/PD-L1 blockade and RANKL inhibitors to treat breast cancers unresponsive to standard therapy [Poster presentation]. BACR 2020, Jette, Belgium.

Pilard, C., RONCARATI, P., Hendrick, E., Lebeau, A., Bruyère, D., Lerho, T., Ancion, M., Reynders, C., DELVENNE, P., Herfs, M., & Hubert, P. (29 January 2020). Combining PD-1/PD-L1 blockade and RANKL inhibitors to treat breast cancers unresponsive to standard therapy [Poster presentation]. Télévie Seminar 2020, Bruxelles, Belgium.

Lebeau, A. (2019). L'infection par HPV altère l'équilibre dynamique du microbiote vaginale par le biais d'une réduction d'expression des peptides antimicrobiens [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/248018

Lebeau, A. (03 October 2019). L’infection par HPV favorise la vaginose bactérienne par le biais d’une réduction d’expression des peptides antimicrobiens [Paper presentation]. 12e Journée de l'AFIPP, Malbuisson, France.

Pilard, C., RONCARATI, P., Lebeau, A., Bruyère, D., Hendrick, E., DELVENNE, P., Herfs, M., & Hubert, P. (21 May 2019). Combining PD-1/PD-L1 blockade and RANKL inhibitors to treat breast cancers unresponsive to standard therapy [Poster presentation]. Immunology Day 2019, Liège, Belgium.

Pilard, C., RONCARATI, P., Lebeau, A., Bruyère, D., Hendrick, E., DELVENNE, P., Herfs, M., & Hubert, P. (01 February 2019). Combining PD-1/PD-L1 blockade and RANKL inhibitors to treat breast cancers unresponsive to standard therapy [Poster presentation]. BACR 2019, Anvers, Belgium.

Lebeau, A. (28 January 2019). HPV-related innate peptide inhibition promotes the acquisition of bacterial/fungal infections within the genital tract [Poster presentation]. Télévie Seminar 2019.

Pilard, C., RONCARATI, P., Lebeau, A., Bruyère, D., Hendrick, E., DELVENNE, P., Herfs, M., & Hubert, P. (28 January 2019). Combining PD-1/PD-L1 blockade and RANKL inhibitors to treat breast cancers unresponsive to standard therapy [Poster presentation]. Télévie Seminar 2019, Gembloux, Belgium.

Song, S., Bruyère, D., Devins, K., Lebeau, A., Reyes, C., & Herfs, M. (2019). Cervical Carcinogenesis, Early Detection and Prevention. In Gynecologic and Obstetric Pathology, Volume 1 (pp. 279-291). Springer.
Peer reviewed

Lebeau, A. (27 September 2018). Infection par HPV et vaginose bactérienne : une association à bénéfice réciproque [Paper presentation]. 11e Journée de l'AFIPP, Obernai, France.

Pilard, C., RONCARATI, P., Lebeau, A., Bruyère, D., Hendrick, E., DELVENNE, P., Herfs, M., & Hubert, P. (13 September 2018). Combining PD-1/PD-L1 blockade and RANKL inhibitors to treat breast cancers unresponsive to standard therapy [Poster presentation]. GIGA-Cancer Day 2018, Liège, Belgium.

Bruyère, D., Lebeau, A., RONCARATI, P., Hendrick, E., Masson, M., Twizere, J.-C., Pilard, C., Hubert, P., DELVENNE, P., & Herfs, M. (30 May 2018). Deciphering the radiosensitivity of HPV-positive tumors [Poster presentation]. 5th meeting on emerging issues in oncogenic virus research, San Pietro in Bevagna, Italy.

Bruyère, D., Lebeau, A., RONCARATI, P., Hendrick, E., Masson, M., Twizere, J.-C., Pilard, C., Hubert, P., DELVENNE, P., & Herfs, M. (28 May 2018). Deciphering the radiosensitivity of HPV-positive tumors [Poster presentation]. EDT-Immunology day 2018, Liège, Belgium.

Lebeau, A., Bruyère, D., Hendrick, E., Pilard, C., RONCARATI, P., TAZIAUX, S., Hubert, P., Delvenne, P., & Herfs, M. (28 May 2018). HPV-related innate peptide inhibition promotes the acquisition of bacterial/fungal infections within the genital tract [Poster presentation]. Immunology day 2018, Liège, Belgium.

Lebeau, A., Bruyère, D., Hendrick, E., Pilard, C., RONCARATI, P., TAZIAUX, S., Hubert, P., Delvenne, P., & Herfs, M. (01 February 2018). HPV-related innate peptide inhibition promotes the acquisition of bacterial/fungal infections within the genital tract [Poster presentation]. Annual Televie seminar, Bruxelles, Belgium.

Herfs, M., RONCARATI, P., KOOPMANSCH, B., Peulen, O., Bruyère, D., Lebeau, A., Hendrick, E., Hubert, P., PONCIN, A., Penny, W., Piazzon, N., Monnien, F., Guenat, D., Mougin, C., Prétet, J.-L., Vuitton, L., SEGERS, K., LAMBERT, F., BOURS, V., ... Delvenne, P. (2018). A dualistic model of primary anal canal adenocarcinoma with distinct cellular origins, etiologies, inflammatory microenvironments and mutational signatures: implications for personalized medicine. British Journal of Cancer, 118(10), 1302-1312. doi:10.1038/s41416-018-0049-2
Peer Reviewed verified by ORBi

Lebeau, A. (28 September 2017). Altered antimicrobial peptide expression in HPV-related (pre)neoplastic lesions [Paper presentation]. Xe Journées scientifiques de l'Association francophone des Infections par Papillomavirus et Polyomavirus, Sainte Foy les Lyon, France.

Lebeau, A., Bruyère, D., RONCARATI, P., DELVENNE, P., Hubert, P., & Herfs, M. (01 February 2017). HPV-mediated innate peptide down-regulation promotes the acquisition of bacterial/fungal infections within the genital tract [Poster presentation]. GIGA Day 2017, Liège, Belgium.

Herfs, M., Longuespée, R., Quick, C., RONCARATI, P., Suarez-Carmona, M., Hubert, P., Lebeau, A., Bruyère, D., Mazzucchelli, G., Smargiasso, N., Baiwir, D., Lai, K., Dunn, A., Obregon, F., Yang, E., De Pauw, E., Crum, C., & Delvenne, P. (2017). Proteomic signatures reveal a dualistic and clinically relevant classification of anal canal carcinoma. Journal of Pathology, 241, 522-533. doi:10.1002/path.4858
Peer Reviewed verified by ORBi

Lebeau, A. (09 December 2016). HPV-mediated innate peptide down-regulation promotes the acquisition of bacterial/fungal infections within the genital tract [Paper presentation]. Séminaire GIGA Cancer, Liège, Belgium.

Lebeau, A., Bruyère, D., RONCARATI, P., Delvenne, P., Hubert, P., & Herfs, M. (08 December 2016). HPV-mediated innate peptide down-regulation promotes the acquisition of bacterial/fungal infections within the genital tract [Poster presentation]. Televie Seminar, Bruxelles, Belgium.

Contact ORBi